Galectin-3 and the Mineralocorticoid Receptor Antagonist Canrenone in Mild Heart Failure
Article 2017 en
Authors
FC
Francesco Clemenza
SM
Serge Masson
PC
Pier Giulio Conaldi
Abstract
1 min read
Although Gal-3 showed prognostic value, the effect of canrenone on clinical outcomes was unaffected by baseline concentrations of biomarkers of fibrosis or cardiac stress.
Diana Hernández‐Romero, Jessica Sánchez-Quiñones, Juan A. Vílchez, José Miguel Rivera‐Caravaca, Gonzalo de la Morena, Professor Gregory Lip, Vicente Climent, Francisco Marı́n
Paul Welsh, Changhong Yu, John J.V. McMurray, Inder S. Anand, Naveed Sattar, Dirk J. van Veldhuisen, Lars Gullestad, Aldo Maggioni, Akshay S. Desai, Scott D. Solomon, Sunfa Cheng, Marc A. Pfeffer, Lei Kou, Karl Swedberg, James B. Young
Discussion(0)
No comments yet. Be the first to comment.